Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab LtdfiledCriticalRanbaxy Lab Ltd
Publication of MY145885ApublicationCriticalpatent/MY145885A/en
A PHARMACEUTICAL COMPOSITION IN THE FORM OF AN ORAL CONTROLLED RELEASE SOLID DOSAGE FORM COMPRISING AN EFFECTIVE AMOUNT OF DRUG, OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS. IT ALSO RELATES TO A PHARMACEUTICALLY COMPOSITION THAT IS SUITABLE FOR ONCE-A-DAY DOSING REGIMEN.
MYPI20023136A2001-08-242002-08-24Controlled release formulations for oral administration
MY145885A
(en)
Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyroolidon as excipient, processes for the preparation and use thereof